Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Adjuvants for Shoulder Arthroplasty
NCT03845894Phase 4Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Mar 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of liposomal bupivacaine in postoperative pain, sponsored by Wake Forest University Health Sciences. Started Mar 2020; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03845894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03845894.